Using bioinformation approaches, we discovered HIBCH and MGME1 as novel biomarkers to identify the underlying processes of mitochondrial dynamics that cause impaired mitochondrial function in Alzheimer's disease, and HIBCH was linked to Tau metabolism. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.